Related Experiment Video
Updated: Jun 16, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Transcription factor co-repressors in cancer biology: roles and targeting
Sebastiano Battaglia1, Orla Maguire, Moray J Campbell
1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.
Abstract:
Normal transcription displays a high degree of flexibility over the choice, timing and magnitude of mRNA expression levels that tend to oscillate and cycle. These processes allow for combinatorial actions, feedback control and fine-tuning. A central role has emerged for the transcriptional co-repressor proteins such as NCOR1, NCOR2/SMRT, CoREST and CTBPs, to control the actions of many transcriptional factors, in large part, by recruitment and activation of a range of chromatin remodeling enzymes. Thus, co-repressors and chromatin remodeling factors are recruited to transcription factors at specific promoter/enhancer regions and execute changes in the chromatin structure. The specificity of this recruitment is controlled in a spatial-temporal manner. By playing a central role in transcriptional control, as they move and target transcription factors, co-repressors act as a key driver in the epigenetic economy of the nucleus. Co-repressor functions are selectively distorted in malignancy, by both loss and gain of function and contribute to the generation of transcriptional rigidity. Features of transcriptional rigidity apparent in cancer cells include the distorted signaling of nuclear receptors and the WNTs/beta-catenin axis. Understanding and predicting the consequences of altered co-repressor expression patterns in cancer cells has diagnostic and prognostic significance, and also have the capacity to be targeted through selective epigenetic therapies.
Insights
Transcriptional co-repressors regulate gene expression flexibility. Aberrant co-repressor function in cancer leads to transcriptional rigidity, offering potential epigenetic therapy targets.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- Gene expression is dynamic, allowing for fine-tuning through oscillating mRNA levels.
- Transcriptional co-repressors (e.g., NCOR1, SMRT) and chromatin remodelers are crucial for controlling gene transcription.
- These factors are recruited spatially and temporally to specific DNA regions to modify chromatin structure.
Purpose of the Study:
- To elucidate the role of co-repressors in maintaining transcriptional flexibility.
- To investigate how co-repressor function is altered in cancer cells.
- To explore the therapeutic potential of targeting co-repressor-mediated transcriptional rigidity.
Main Methods:
- Analysis of co-repressor recruitment dynamics to promoter/enhancer regions.
- Investigation of spatial-temporal control mechanisms in co-repressor targeting.
- Examination of co-repressor function in cancer cell signaling pathways (e.g., nuclear receptors, WNT/beta-catenin).
Main Results:
- Co-repressors are key regulators of the nucleus's epigenetic economy by controlling transcription factors.
- Co-repressor functions are distorted in malignancy through loss or gain of function, causing transcriptional rigidity.
- Cancer cells exhibit transcriptional rigidity, evidenced by altered nuclear receptor and WNT/beta-catenin signaling.
Conclusions:
- Altered co-repressor expression patterns in cancer have diagnostic and prognostic implications.
- Understanding these alterations can guide the development of targeted epigenetic therapies for cancer.
- Co-repressors represent a critical node in cancer biology that can be therapeutically exploited.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
03:37Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Master Transcription Regulators